vTv Therapeutics, Inc. (VTVT)
31.06
+0.98
(+3.27%)
USD |
NASDAQ |
Oct 09, 16:00
31.06
0.00 (0.00%)
After-Hours: 19:14
vTv Therapeutics Total Liabilities (Quarterly) : 8.961M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.961M |
| March 31, 2026 | 8.854M |
| December 31, 2025 | 25.46M |
| September 30, 2025 | 28.95M |
| June 30, 2025 | 24.04M |
| March 31, 2025 | 23.13M |
| December 31, 2024 | 23.96M |
| September 30, 2024 | 25.25M |
| June 30, 2024 | 26.02M |
| March 31, 2024 | 28.20M |
| December 31, 2023 | 29.57M |
| September 30, 2023 | 29.44M |
| June 30, 2023 | 28.83M |
| March 31, 2023 | 28.42M |
| December 31, 2022 | 27.40M |
| September 30, 2022 | 27.88M |
| June 30, 2022 | 29.60M |
| March 31, 2022 | 13.91M |
| December 31, 2021 | 10.25M |
| September 30, 2021 | 8.369M |
| June 30, 2021 | 9.293M |
| March 31, 2021 | 10.38M |
| December 31, 2020 | 11.00M |
| Date | Value |
|---|---|
| September 30, 2020 | 12.83M |
| June 30, 2020 | 16.78M |
| March 31, 2020 | 17.01M |
| December 31, 2019 | 18.11M |
| September 30, 2019 | 19.00M |
| June 30, 2019 | 21.91M |
| March 31, 2019 | 23.36M |
| December 31, 2018 | 28.93M |
| September 30, 2018 | 35.16M |
| June 30, 2018 | 43.41M |
| March 31, 2018 | 43.12M |
| December 31, 2017 | 47.52M |
| September 30, 2017 | 29.72M |
| June 30, 2017 | 30.04M |
| March 31, 2017 | 30.14M |
| December 31, 2016 | 22.92M |
| September 30, 2016 | 10.81M |
| June 30, 2016 | 10.05M |
| March 31, 2016 | 8.911M |
| December 31, 2015 | 7.971M |
| September 30, 2015 | 6.129M |
| June 30, 2015 | 99.91M |
| March 31, 2015 | 6.176M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.59M |
| Shareholders Equity (Quarterly) | 78.63M |
| Current Ratio | 12.48 |
| Net Debt Paydown Yield | 0.02% |